NCT00410228View on ClinicalTrials.gov

Study to Explore the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral AHT956 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

June 30, 2006

Conditions
Healthy
Interventions
DRUG

AHT956

Trial Locations (1)

Unknown

Novartis Investigative Site, Bern

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY

NCT00410228 - Study to Explore the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral AHT956 in Healthy Subjects | Biotech Hunter | Biotech Hunter